COWEN COLLABORATIVE INSIGHTS 68 February 25, 2019 Competition From AMZN Private Label Could Be A LT Concern, Offset By CBD’s Established Brands Should the market for CBD products expand rapidly over the next several years, one source for increased competition could be Amazon'...
Results for “Filmmaker’s Collaborative”
Search across the indexed text of every released document.
Names that match “Filmmaker’s Collaborative”
116 documents found
COWEN COLLABORATIVE INSIGHTS 76 February 25, 2019 supplements, regardless of whether the substances are hemp-derived. This is because both CBD and THC are active ingredients in FDA-approved drugs and were the subject of substantial clinical investigations before they were mark...
COWEN COLLABORATIVE INSIGHTS 70 February 25, 2019 Growing Application For Hemp And CBD Within The Apparel & Footwear Market (Kernan) With the changing tide on marijuana legalization and hemp cultivation, the use case for and interest in CBD applications are rapidly expanding....
COWEN COLLABORATIVE INSIGHTS February 25, 2019 Nutraceuticals Given robust consumer interest in CBD products, we estimate that over the next two years, the nutraceuticals category (which includes tinctures, capsules, gummy vitamins, etc.) can generate revenues of $2.4 bn. Unce...
COWEN COLLABORATIVE INSIGHTS 62 February 25, 2019 e Mary’s Whole Pet. Whole plant CBD remedies for pets, sold in retailers and online in the U.S. and international markets. Mary’s is a high-end brand, focused on clean delivery methods through its transdermal patches, topical...
COWEN COLLABORATIVE INSIGHTS (1):$15.00 024/17 Jul 16 1:(1):$13.00 01/10/17 100 80 60 40 20 0 Apr 16 Legend for Price Chart: (1):$10.00 06/14/17 Oct 16 Canopy Growth Corporation Rating History as of 02/25/2019 Jan 17 February 25, 2019 powered by: BlueMatrix (1):$10.50...
and physiological features of a heart attack, including chest pain, abnormalities on the electrocardiogram, and elevated cardiac enzymes (reflecting damaged heart muscle) (2). The condition has variously been termed takotsubo cardiomyopathy, left- ventricular apical ballooning, m...
COWEN COLLABORATIVE INSIGHTS 92 February 25, 2019 Figure 128 Pooled LGS % Seizure Reduction: 10mg/kg Epidiolex vs. Figure 129 Pooled LGS % Seizure Reduction: 20mg/kg Epidiolex vs. Placebo Placebo 100, our 100, oe 100 oars =79] (30% on VPA 100 pa =83] (38% on CLB Placebo [n=3...
4.2.12 WC: 191694 As I previously mentioned, my initial assignment as Justice Goldberg’s law clerk was to write a memorandum on the possible unconstitutionality of the death penalty. Here is how [ find author] , in his book , describes the origins of this lifelong collaborative...
COWEN COLLABORATIVE INSIGHTS 38 February 25, 2019 Beverages Over the next two years, we believe that the beverage category can grow to a $900 mm revenue opportunity. Our conviction in this category is underscored by our proprietary consumer survey, which shows that almost 20%...
COWEN COLLABORATIVE INSIGHTS Figure 18 Interest Broad Based from Edibles... February 25, 2019 Consumer Products Opportunities (Azer) In 2018, the CBD market in the U.S. has been estimated to have generated revenues ranging from ~S600 mm to as much as $2 bn. In our 2019 globa...
COWEN COLLABORATIVE INSIGHTS February 25, 2019 The below figure reflects the notable competition seen within vape as more companies continue to enter the space. In addition to CBD only-focused companies, we are starting to see crossover from adult-use / medical focused companie...
COWEN COLLABORATIVE INSIGHTS Figure 110 Prime Member Purchaser % By Vertical, 1918-4018 February 25, 2019 Figure 109 Share Of U.S. eCommerce Sales '13 vs. ‘18E vs. ‘23E Office Equip/Supplies Garden Equip/Supplies Toys Sporting Goods Other 100% 90% 80% Media Auto 70% Foo...
COWEN COLLABORATIVE INSIGHTS 80 February 25, 2019 European Landscape European Parliament Resolution In February 2019, the European Parliament passed a significant resolution to create harmonized policies and standardized practices for medical cannabis products in the EV. The...
NEW LEAF VENTURES III, L.P. – $375 MILLION LIMITED PARTNER INTERESTS – CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM APRIL, 2014 Control No. 257 NEW LEAF VENTURES III, L.P. – $375 MILLION LIMITED PARTNER INTERESTS – CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM APRIL, 2014 NEW LEAF VENT...